A detailed history of New York State Common Retirement Fund transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, New York State Common Retirement Fund holds 229,037 shares of ROIV stock, worth $4.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
229,037
Previous 182,693 25.37%
Holding current value
$4.65 Million
Previous $2.06 Million 68.37%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$10.74 - $15.28 $497,734 - $708,136
46,344 Added 25.37%
229,037 $3.47 Million
Q2 2025

Oct 08, 2025

SELL
$9.08 - $11.62 $78,996 - $101,094
-8,700 Reduced 4.55%
182,693 $2.06 Million
Q2 2025

Aug 13, 2025

SELL
$9.08 - $11.62 $78,996 - $101,094
-8,700 Reduced 4.55%
182,693 $2.06 Million
Q1 2025

Oct 08, 2025

SELL
$10.09 - $12.08 $286,556 - $343,072
-28,400 Reduced 12.92%
191,393 $1.93 Million
Q1 2025

May 01, 2025

SELL
$10.09 - $12.08 $286,556 - $343,072
-28,400 Reduced 12.92%
191,393 $1.93 Million
Q4 2024

Oct 08, 2025

BUY
$11.16 - $12.71 $323,640 - $368,590
29,000 Added 15.2%
219,793 $2.6 Million
Q4 2024

Jan 31, 2025

BUY
$11.16 - $12.71 $323,640 - $368,590
29,000 Added 15.2%
219,793 $2.6 Million
Q3 2024

Oct 08, 2025

BUY
$10.17 - $12.5 $82,377 - $101,250
8,100 Added 4.43%
190,793 $2.2 Million
Q3 2024

Oct 28, 2024

SELL
$10.17 - $12.5 $266,454 - $327,500
-26,200 Reduced 12.07%
190,793 $2.2 Million
Q2 2024

Oct 08, 2025

BUY
$10.36 - $11.74 $355,348 - $402,682
34,300 Added 18.77%
216,993 $2.29 Million
Q2 2024

Jul 31, 2024

BUY
$10.36 - $11.74 $2,134 - $2,418
206 Added 0.1%
216,993 $2.29 Million
Q1 2024

Oct 08, 2025

BUY
$9.87 - $11.8 $336,507 - $402,309
34,094 Added 18.66%
216,787 $2.28 Million
Q1 2024

May 07, 2024

SELL
$9.87 - $11.8 $506,380 - $605,399
-51,305 Reduced 19.14%
216,787 $2.29 Million
Q4 2023

Oct 08, 2025

BUY
$8.38 - $11.58 $715,643 - $988,920
85,399 Added 46.74%
268,092 $3.01 Million
Q4 2023

Feb 01, 2024

SELL
$8.38 - $11.58 $538,171 - $743,679
-64,221 Reduced 19.33%
268,092 $3.01 Million
Q3 2023

Oct 08, 2025

BUY
$9.76 - $13.19 $1.46 Million - $1.97 Million
149,620 Added 81.9%
332,313 $3.88 Million
Q3 2023

Nov 07, 2023

BUY
$9.76 - $13.19 $89,957 - $121,572
9,217 Added 2.85%
332,313 $3.88 Million
Q2 2023

Oct 08, 2025

BUY
$7.09 - $10.08 $995,457 - $1.42 Million
140,403 Added 76.85%
323,096 $3.26 Million
Q2 2023

Aug 07, 2023

BUY
$7.09 - $10.08 $2.2 Million - $3.13 Million
310,925 Added 2554.64%
323,096 $3.26 Million
Q1 2023

Oct 08, 2025

SELL
$6.92 - $9.98 $1.18 Million - $1.7 Million
-170,522 Reduced 93.34%
12,171 $89,000
Q1 2023

May 02, 2023

BUY
$6.92 - $9.98 $84,223 - $121,466
12,171 New
12,171 $90,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $14.3B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.